Bill

Bill > S689


MA S689

Relative to the care and treatment of patients with mitochondrial disease


summary

Introduced
03/29/2021
In Committee
02/17/2022
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

For legislation relative to the care and treatment of patients with mitochondrial disease. Financial Services.

AI Summary

This bill requires that health insurance plans provided by the Commonwealth of Massachusetts, as well as individual and group health plans more broadly, must cover treatment for mitochondrial disease. The covered treatments include the use of various vitamin and nutritional supplements such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1, and L-Carnitine. This legislation aims to ensure that patients with mitochondrial disease have access to the necessary treatments and nutritional supplements through their health insurance plans.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (1)

Last Action

Accompanied a study order, see S2917 (on 06/09/2022)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...